PINK1 and Parkinson disease: NCLX inhibition has been indicated in a familial form of Parkinson's disease, in which PINK-1 deficiency leads to a delayed Ca2+ efflux and mitochondrial Ca2+ overload in response to physiological Ca2+ stimulation (Glancy and Balaban, 2012).